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Missense variants in TTN were not considered because these variants are highly prevalent 
in the general population and vastly exceed the frequency of cardiomyopathy, making them 






































Even though the changes in the sodium current suggest a pathogenic role, we consider some 





















































































































causing amino acid 
change or residue, 
functional studies, 
preva- lence of the 
variants in affected 
individuals with 
the asso- ciated 






de novo, co- 
segregation studies 
and a minor-alele 
frequency (MAF) 
below the disease 
prevalence.!
Based on a 
scoring 
scheme based 





VUS 0, 1, 2 





The study shows the potential of genetic analysis of a large number of genes associated 
with cardiac diseases in forensic med- icine with the use of NGS, as approximately one 









































































































































































































































































































































































































































































































































































































































































































































































variant that is 
known to be 
pathogenic in one 
member of a 
protein family is 
used to annotate 
the equivalent 
amino acid of other 
members of the 
family for which 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1 1.2 1.4 1.6 1.8 2
VUS sub-classification
decision regret Fited values
1 = VUS-Low; 2 = VUS-High























































































































































































































































































































































































































































































































































Table 5.2: Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
       1 |      34    4.658088    .1625188     .947639    4.327441    4.988735 
       2 |      45    4.653175    .1360332    .9125387    4.379018    4.927332 
---------+-------------------------------------------------------------------- 
combined |      79    4.655289    .1037085    .9217813    4.448822    4.861757 
---------+-------------------------------------------------------------------- 
    diff |            .0049136    .2108124               -.4148675    .4246947 
------------------------------------------------------------------------------ 
    diff = mean(1) - mean(2)                                      t =   0.0233 
Ho: diff = 0                                     degrees of freedom =       77 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
































































' Intentions' Resilience' Optimism' Tolerance'of'
Uncertainty'






























Coeficient'' Β' Std.'Err.' ''t' p?value'
Perceived'Risk' .1217759! .118306! .0932895! 1.31! 0.196!
Perceived'
Severity'




.6992928! .5299557! .1269975! 5.51! 0.000'*'
Self?eficacy' .1824311! .1731582! .1017038! 1.79! 0.077!

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Schematic diagram of a patient with a normal heart (left) and a patient with hypertrophic 
cardiomyopathy (right). 
Nishimura R A et al. Circulation. 2003;108:e133-e135 
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� � � �
� � �
�
���How confident are you that the estimate you gave in Q14 above is accurate? (that it 










� � � �
� � �
�
���In Q11 and Q14, you indicated your beliefs about how likely it is that you wil get cardiomyopathy. 
However, at a gut-level, you might feel more or less vulnerable than your response above suggests. How likely 





















� � � �
� � �
� ���
���How confident are you that the estimate you gave in Q17 above is accurate? (that it 



















* 20. Through ClinSeq you learned you have a variant related to cardiomyopathy. Please respond to the folowing 
statements about that result. 
�














































* 23. Please rate how strongly you agree with each of the folowing  statements. 
�
������






























* 24. Please rate your response to the folowing statements 
�



















���Please think about the decision you made about receiving this genetic VUS result. Please show how 











































arrhythmogenic! right! ventricular! cardiomyopathy! (ARVC),! centronuclear! myopathy!

























Dilated' Cardiomyopathy' (DCM)' and' Arrhythmogenic' Right' Ventricular'
Cardiomyopathy'(ARVC)'
Cardiomyopathy!is!a!disease!of!the!heart!muscle!that!makes!it!dificult!for!the!heart!to!
perform! its! main! function! of! pumping! blood! to! the! rest! of! the! body.!!This! can! lead! to!
symptoms!such!as:!feeling!tired!(especialy!when!exercising),!fainting,!or!having!irregular!
heartbeats.!Over!time,!the!damage!to!the!heart!becomes!more!severe!and!can!lead!to!







































weakness! and! wasting! appearing! after! age! 35.!  This! muscle! controls! the! up(and(down!
movement! of! the!foot;!therefore,!weakness! of! this! muscle! may! lead! to! dificulty! with!















Sudden! cardiac! death! occurs! due! to! problems! with! the! electrical! system! of! the! heart,!






























TTN!gene! (like! you)! should! be! screened! for!cardiomyopathy,! muscular! dystrophy! or!
myopathy.!If!you!are!concerned!about!your!risk!to!develop!these!conditions,!we!suggest!
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